I'd like to start this post by first aknowledging those who forecast MSB would be bankrupt last year and would not be able to complete the next round of required funding or clinical trials. And well...MSB is still here, they have 12 months of cash, the Back Pain trial setup/recruitment has started, the adult GvHD trial with an anticipated shorter end point is about to commence.
I always thought the results were compelling, and there are those who trashed the results at every turn possible. Judgmenet day will be coming for both of us soon. 2 new trials, 2 new sets of results, if they meet the primary end points....I expect them to be blockbusters, particularly Back Pain. So much potential ! Walk in, walk out, least ammount of cells of any of MSB's product, cheaper than surgery, no addiction side effects noted, long lasting pain relief.
Will we get an early halt from the DMSB in 2024..... I hope so.
-
- There are more pages in this discussion • 885 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
0.185(11.2%) |
Mkt cap ! $2.351B | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.84 | $1.65 | $13.70M | 7.781M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.84 | 33618 | 8 |
View Market Depth
| Last trade - 16.19pm 01/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |